2. Gene
  3. NAXE - NAD(P)HX epimerase Gene

NAXE - NAD(P)HX epimerase Gene

  • Gene
  • Protein
  • Disease
  • Agent
  • Ortholog
Homo sapiens

Also known as AIBP; PEBEL; YJEFN1; APOA1BP

Gene ID: 128240 | Gene type: protein coding

About NAXE

Cytogenetic location: 1q22 Genomic coordinates (GRCh38): 1:156,591,776-156,594,299 (from NCBI)

This gene has 20 transcripts (splice variants), 193 orthologues, 1 paralogue and is associated with 3 phenotypes. Ubiquitous expression in kidney (RPKM 11.3), prostate (RPKM 10.3) and 25 other tissues.

Summary

The product of this gene interacts with apolipoprotein A-I (apoA-I), the major apolipoprotein of high-density lipoproteins (HDLs). It is secreted into some bodily fluids, and its synthesis and secretion are stimulated in vitro by incubating cells with apoA-I. The human genome contains related pseudogenes. [provided by RefSeq, Jul 2008]

NAXE Products(1)

mRNA Protein Name
NM_144772.3 NP_658985.2 NAD(P)H-hydrate epimerase precursor

NAXE Protein Structure

YjeF_N

YjeF_N: YjeF-related protein N-terminus (81 - 246)

  • 0
  • 100
  • 200
  • 288 a.a.
Protein Preferred Names Protein Names

NAD(P)H-hydrate epimerase

AI-BP

Recombinant NAXE Proteins

Cat. No. Product Name Accession Purity
HY-P76155 APOA1BP Protein, Human (HEK293, His) Q8NCW5 (M1-Q288) ≥95%

Related Diseases

Diseases Alias
Encephalopathy, Progressive, Early-Onset, With Brain Edema And/Or Leukoencephalopathy, 1

Encephalopathy, Progressive, Early-Onset, With Brain Edema And/Or Leukoencephalopathy

PEBEL1

Pebel

Nad Hx Epimerase Deficiency

Apolipoprotein A-I Binding Protein Deficiency

Encephalopathy, Progressive, Early-Onset, With Brain Edema And/Or Leukoencephalopathy 1

Encephalopathy, Progressive, Early-Onset, With Brain Edema And/Or Leukoencephalopathy, Type 1
Spastic Paraplegia 46, Autosomal Recessive

SPG46

Hereditary Spastic Paraplegia 46

Autosomal Recessive Spastic Paraplegia Type 46

Autosomal Recessive Spastic Paraplegia 46

Paraplegia, Spastic, Type 46, Autosomal Recessive
L-2-Hydroxyglutaric Aciduria

L-2-Hydroxyglutaric Acidemia

L2HGA

L-2-Hga

Aciduria, L-2-Hydroxyglutaric

Combined D-2- And L-2-Hydroxyglutaric Aciduria
2-Hydroxyglutaric Aciduria

2-Hga

2-Hydroxyglutaric Acidemia

2-Hydroxyglutaricaciduria

Combined D-2- And L-2-Hydroxyglutaric Aciduria
Brain Edema

Cerebral Edema

Intracranial Swelling

Wet Brain
Spinocerebellar Ataxia 28

Spinocerebellar Ataxia Type 28

SCA28

Ataxia, Spinocerebellar, Type 28
Diseases Alias
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Related Agents

Pre-clinical Phase
Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-RS09050 NAXE Human Pre-designed siRNA Set A Pre-designed Sets / Unkown

Orthologs Information

Species Symbol Source ID
Bos taurus NAXE VGNC VGNC:55632
Felis catus NAXE VGNC VGNC:107900
Mus musculus NAXE MGD MGI:2180167
Canis familiaris NAXE VGNC VGNC:53623
Macaca mulatta NAXE VGNC VGNC:100018
Rattus norvegicus NAXE RGD RGD:1304699
Others NAXE NCBI